Difference between revisions of "Restrictive cardiomyopathy"
(Text replacement - "e/o" to "evidence of") |
Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==") |
||
| Line 18: | Line 18: | ||
**Metastatic disease, carcinoid syndrome | **Metastatic disease, carcinoid syndrome | ||
| − | == | + | ==Evaluation== |
*Consider if CHF but no evidence of cardiomegaly or systolic dysfunction | *Consider if CHF but no evidence of cardiomegaly or systolic dysfunction | ||
Revision as of 00:06, 23 July 2016
Contents
Background
- Muscle is stiff from fibrosis or infiltrating process
- EF is usually normal
- Form of diastolic dysfunction (difficulty filling)
- Must distinguish from constrictive pericarditis
Differential Diagnosis
Cardiomyopathy
- Dilated cardiomyopathy
- Hypertrophic cardiomyopathy
- Restrictive cardiomyopathy
- Peripartum cardiomyopathy
- Takotsubo cardiomyopathy
- Arrhythmogenic right ventricular dysplasia
- Restrictive cardiomyopathy ddx
- Idiopathic
- Familial noninfiltrative disease
- Infiltrative disease (amyloidosis, sarcoidosis, Gaucher, Hurler)
- Storage diseases (hemachromatosis, Fabry, glycogen/lysosomal storage diseases)
- Diabetes
- Scleroderma
- Endomyocardial fibrosis (hypereosinophilic syndrome, medication toxicity)
- Radiation, chemotherapy (doxorubicin)
- Metastatic disease, carcinoid syndrome
Evaluation
- Consider if CHF but no evidence of cardiomegaly or systolic dysfunction
Management
- Symptom directed (diuretics and ACEI)
See Also
References
Authors:
Daniel Eggeman, Claire, Kevin Lu, Neil Young, Daniel Ostermayer, Ross Donaldson